Comparative phase III clinical trial of two injectable contraceptive preparations, depot-medroxyprogesterone acetate and cyclofem, in vietnamese women

Contraception

Volumn 54, Issue 3, 1996, Pages 169-179

  Cuong, D T ^a   My Huong, N T ^a   D'Arcangues, Catherine ^b  

^a Inst for the Protect of M   (Viet Nam)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

contraception; Cyclofem; DMPA; injectable; Viet Nam

Indexed keywords

ESTRADIOL CYPIONATE PLUS MEDROXYPROGESTERONE ACETATE; MEDROXYPROGESTERONE ACETATE;

ADULT; AMENORRHEA; ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; FEMALE; HORMONAL CONTRACEPTION; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; INTRAMUSCULAR DRUG ADMINISTRATION; MULTICENTER STUDY; NORMAL HUMAN; PATIENT SATISFACTION; PHASE 3 CLINICAL TRIAL; PREGNANCY; VAGINA BLEEDING; VIET NAM;

EID: 0030250699     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0010-7824(96)00173-4     Document Type: Article

References (12)

1. 1. Viet Nam Intercensal Demographic Survey, 1994. Major findings. Hanoi: Statistical Publishing House, 1995: 147.
2. 2. World Health Organization. Special Programme of Research, Development and Research Training in Human Reproduction. Facts about once-a-month injectable contraceptives: Memorandum from a WHO meeting. Bull WHO 1993;70:677-89.
3. 3. Fraser IS. Vaginal bleeding patterns in women using once-a-month injectable contraceptives. Contraception 1994;49:399-420.
4. 4. Koetsawang S. Once-a-month injectable contraceptives: efficacy and reasons for discontinuation. Contraception 1994;49:387-98.
5. 5. Hall PE. Task Force on Research on Introduction and Transfer of Technologies for Fertility Regulation, Special Programme of Research, Development and Research Training in Human Reproduction. The introduction of Cyclofem in national family planning programmes: experience from studies in Indonesia, Jamaica, Mexico, Thailand and Tunisia. Contraception 1994;49:489-507.
6. 6. d'Arcangues C, Odlind V, Fraser I. Dysfunctional uterine bleeding induced by exogenous hormones. In: Alexander NJ, d'Arcangues C, eds. Steroid hormones and uterine bleeding. Washington:American Association for the Advancement of Science, 1992:81-105.
7. 7. Rodriguez G, Faundes-Latham A, Atkinson LE. An approach to the analysis of menstrual patterns in the critical evaluation of contraceptives. Stud Fam Plann 1976; 7:42-51.
8. 8. Belsey EM, Machin D, d'Arcangues C. The analysis of vaginal bleeding patterns induced by fertility regulating methods. Contraception 1986;34:253-60.
9. 9. Pinol A, Machin D. A micro-computer software for the analysis of menstrual diaries: the Menstrual Diary System. Contraception 1988;38:157-63
10. 10. Newton JR, d'Arcangues C, Hall PE. "Once-a-month" combined injectable contraceptives. J Ob Gyn 1994;14 (suppl. 1):S1-S34.
11. 11. World Health Organization. Special Programme of Research, Development and Research Training in Human Reproduction. Facts about injectable contraceptives. Bull WHO 1982;60:199-210.
12. 12. Garza-Flores J, Sang G-W, Hall PE. Population and delivery systems: Variability in the pharmacokinetics of long-acting injectable contraceptives. In: Snow R, Hall PE, eds. Steroid contraceptives and women's response. Regional variability in side effects and pharmacokinetics. New York:Plenum Press, 1994:69-83.